It has been reported that HGF-induced Met activation exerts beneficial neuroprotective effects in preclinical models of cerebral ischaemia, spinal cord injuries and neurological pathologies, such as Alzheimer’s disease, amyotrophic lateral sclerosis and multiple sclerosis35. The gene discussed is MET; the disease is early-onset autosomal dominant Alzheimer disease.